Moderna CEO on Covid Strategies, Monkeypox Concerns

The video discusses the current state of COVID-19, highlighting complacency and booster fatigue. It covers vaccine development, efficacy, and the need for annual boosters, especially for high-risk groups. The challenges of global vaccine distribution and acceptance, particularly in China and emerging markets, are addressed. Moderna's platform and future developments, including mRNA technology, are explored. The video also touches on regulatory speed, charitable efforts in vaccine distribution, and the importance of monitoring new diseases like monkeypox to prepare for future pandemics.

What is the speaker's opinion on the sustainability of China's zero COVID policy?

How does the speaker suggest addressing the issue of monkeypox?

What strategies are being discussed to prepare for future pandemics?